Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

0R1B

Biogen (0R1B)

Biogen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0R1B
DateTimeSourceHeadlineSymbolCompany
06/03/202423:30UK RegulatoryNew Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene TherapyLSE:0R1BBiogen Inc
05/03/202408:15UK RegulatoryBiogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual MeetingLSE:0R1BBiogen Inc
23/02/202423:00UK RegulatoryBiogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMPLSE:0R1BBiogen Inc
13/02/202408:06UK RegulatoryBiogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s AtaxiaLSE:0R1BBiogen Inc
31/01/202423:30UK RegulatoryBiogen to Realign Resources for Alzheimer's Disease FranchiseLSE:0R1BBiogen Inc
07/08/202302:07Alliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:0R1BBiogen Inc
06/08/202323:17Alliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:0R1BBiogen Inc
09/06/202321:12Alliance NewsAlliance News*Nasdaq halts trading of Biogen stockLSE:0R1BBiogen Inc
14/01/202001:28Alliance NewsAlliance NewsPfizer Could Net USD635 Million As Biogen Acquires Alzheimer's DrugLSE:0R1BBiogen Inc
 Showing the most relevant articles for your search:LSE:0R1B

Your Recent History

Delayed Upgrade Clock